Stock Fundamentals

Company Information

▼
Company Name
Enlivex Therapeutics Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: IL0011319527
CIK: 0000919794
CUSIP: M20156127
Currency: USD
Full Time Employees: 0
Phone: 972 2 620 8072
Website: https://www.enlivex.com
Fiscal Year End: December
IPO Date: Dec 12, 1995
Description:

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.

Address:

14 Einstein Street, Ness Ziona, Israel, 7403618

Directors & Officers

▼
Name Title Year Born
Mr. Shai Novik M.B.A. Executive Chairman 1966
Dr. Oren Hershkovitz Ph.D. Chief Executive Officer 1977
Prof. Dror Mevorach M.D. Founder & Scientific Advisor 1956
Ms. Shachar Shlosberger CPA Chief Financial Officer 1977
Dr. Veronique Amor-Baroukh Senior Director of Operations NA
Ms. Sigal Arad Director of Human Resources NA
Dr. Einat Galamidi M.D. Chief Medical Officer 1974

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Renaissance Technologies Corp 313.63K Dec 31, 2025 0.13% $0.00 99.39%
Citizens Financial Group Inc 231.42K Sep 30, 2025 0.10% $0.00 0.00%
Two Sigma Investments LLC 195.13K Dec 31, 2025 0.08% $0.00 1,716.98%
Morgan Stanley - Brokerage Accounts 173.63K Sep 30, 2025 0.07% $0.00 -20.77%
HRT FINANCIAL LLC 153.99K Dec 31, 2025 0.06% $0.00 719.44%
Citadel Advisors Llc 68.94K Sep 30, 2025 0.03% $0.00 0.00%
Susquehanna International Group, LLP 54.85K Sep 30, 2025 0.02% $0.00 0.00%
XTX Topco Ltd 42.67K Sep 30, 2025 0.02% $0.00 0.00%
TWO SIGMA SECURITIES, LLC 34.24K Sep 30, 2025 0.01% $0.01 0.00%
Jane Street Group LLC 21.53K Sep 30, 2025 0.01% $0.00 -64.74%
Prosperity Consulting Group, LLC 17.65K Dec 31, 2025 0.01% $0.00 0.00%
Neuberger Berman Group LLC 10.99K Sep 30, 2025 0.00% $0.00 0.00%
Wells Fargo & Co 9.18K Sep 30, 2025 0.00% $0.00 0.00%
Group One Trading, LP 7.00K Sep 30, 2025 0.00% $0.00 0.00%
SignatureFD, LLC 5.00K Sep 30, 2025 0.00% $0.00 0.00%
UBS Group AG 4.04K Sep 30, 2025 0.00% $0.00 0.00%
Steward Partners Investment Advisory, LLC 2.50K Sep 30, 2025 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 2.13K Sep 30, 2025 0.00% $0.00 -70.18%
SRS Capital Advisors Inc 1.02K Sep 30, 2025 0.00% $0.00 0.00%
Bfsg, LLC 1.00K Dec 31, 2025 0.00% $0.00 0.00%

Shares Statistics

▼
Shares Outstanding: 237.38M
Shares Float: 6.28M
% Insiders: 46.30%
% Institutions: 82.20%
Short % Float: 0.22%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Renaissance Technologies Corp 313.63K 0.13% ▲ 99.39% Dec 31, 2025
2 Citizens Financial Group Inc 231.42K 0.10% ▲ 0.00% Sep 30, 2025
3 Two Sigma Investments LLC 195.13K 0.08% ▲ 1,716.98% Dec 31, 2025
4 Morgan Stanley - Brokerage Accounts 173.63K 0.07% ▼ 20.77% Sep 30, 2025
5 HRT FINANCIAL LLC 153.99K 0.06% ▲ 719.44% Dec 31, 2025
6 Citadel Advisors Llc 68.94K 0.03% ▲ 0.00% Sep 30, 2025
7 Susquehanna International Group, LLP 54.85K 0.02% ▲ 0.00% Sep 30, 2025
8 XTX Topco Ltd 42.67K 0.02% ▲ 0.00% Sep 30, 2025
9 TWO SIGMA SECURITIES, LLC 34.24K 0.01% ▲ 0.00% Sep 30, 2025
10 Jane Street Group LLC 21.53K 0.01% ▼ 64.74% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $255.49M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $272.99M
EBITDA: $-14.33M
Book Value: $0.72
Earnings/Share: $-0.54
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -36.02%
ROE (TTM): -57.64%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 6.84x 0.02x 0.15x -1,195.08x -0.03x
2023-12-31 5.57x 0.01x 0.18x -2,099.64x -0.01x
2022-12-31 7.92x 0.01x 0.16x -4.90x -0.03x
2021-12-31 18.32x 0.01x 0.11x -58.80x -0.03x
2020-12-31 8.72x 0.01x 0.12x -1,630.83x -0.02x
2019-12-31 2.75x 0.01x 0.36x -1,231.29x -0.01x
2018-12-31 9.09x 0.00x 0.12x N/A 0.00x
2017-12-31 7.87x 0.00x 0.13x N/A 0.00x
2016-12-31 5.46x 0.00x 0.18x N/A 0.00x
2015-12-31 8.11x 0.00x 0.13x N/A 0.00x
2014-12-31 14.42x 0.00x 0.07x N/A 0.00x
2013-12-31 43.35x 0.00x 0.02x -574.00x 0.00x
2012-12-31 1.93x 0.00x 0.52x N/A 0.00x
2007-12-31 0.00x 0.14x 0.33x N/A N/A
2006-12-31 0.00x 0.20x 0.27x N/A N/A
2005-12-31 0.00x 0.10x 0.21x N/A N/A
2004-12-31 0.00x 0.07x 0.22x N/A N/A
2003-12-31 0.00x 0.17x 0.40x N/A N/A
2002-12-31 0.00x 0.17x 0.28x N/A N/A
2001-12-31 0.00x 0.00x 0.15x N/A N/A
2000-12-31 0.00x 0.00x 0.06x N/A N/A

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ENLV.US!